Literature DB >> 32206160

Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine.

Roy Elias1,2, Akanksha Sharma1, Nirmish Singla3, James Brugarolas1,2.   

Abstract

Entities:  

Keywords:  BAP1; Kidney cancer; PBRM1; genomics; immune checkpoint inhibitor; molecularly targeted therapies; next generation sequencing; renal cell carcinoma

Year:  2019        PMID： 32206160      PMCID： PMC7089604     

Source DB:  PubMed          Journal:  Kidney Cancer J        ISSN： 1933-0863


× No keyword cloud information.
  107 in total

1.  Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality.

Authors:  Denise A Chan; Patrick D Sutphin; Phuong Nguyen; Sandra Turcotte; Edwin W Lai; Alice Banh; Gloria E Reynolds; Jen-Tsan Chi; Jason Wu; David E Solow-Cordero; Muriel Bonnet; Jack U Flanagan; Donna M Bouley; Edward E Graves; William A Denny; Michael P Hay; Amato J Giaccia
Journal:  Sci Transl Med       Date:  2011-08-03       Impact factor: 17.956

2.  ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

Authors:  Samira A Brooks; A Rose Brannon; Joel S Parker; Jennifer C Fisher; Oishee Sen; Michael W Kattan; A Ari Hakimi; James J Hsieh; Toni K Choueiri; Pheroze Tamboli; Jodi K Maranchie; Peter Hinds; C Ryan Miller; Matthew E Nielsen; W Kimryn Rathmell
Journal:  Eur Urol       Date:  2014-02-25       Impact factor: 20.096

3.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; F M Duh; F Chen; T Kishida; G Glenn; P Choyke; S W Scherer; Z Zhuang; I Lubensky; M Dean; R Allikmets; A Chidambaram; U R Bergerheim; J T Feltis; C Casadevall; A Zamarron; M Bernues; S Richard; C J Lips; M M Walther; L C Tsui; L Geil; M L Orcutt; T Stackhouse; J Lipan; L Slife; H Brauch; J Decker; G Niehans; M D Hughson; H Moch; S Storkel; M I Lerman; W M Linehan; B Zbar
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Loss of the tumor suppressor BAP1 causes myeloid transformation.

Authors:  Anwesha Dey; Dhaya Seshasayee; Rajkumar Noubade; Dorothy M French; Jinfeng Liu; Mira S Chaurushiya; Donald S Kirkpatrick; Victoria C Pham; Jennie R Lill; Corey E Bakalarski; Jiansheng Wu; Lilian Phu; Paula Katavolos; Lindsay M LaFave; Omar Abdel-Wahab; Zora Modrusan; Somasekar Seshagiri; Ken Dong; Zhonghua Lin; Mercedesz Balazs; Rowena Suriben; Kim Newton; Sarah Hymowitz; Guillermo Garcia-Manero; Flavius Martin; Ross L Levine; Vishva M Dixit
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

5.  HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Authors:  Stefano J Mandriota; Kevin J Turner; David R Davies; Paul G Murray; Neil V Morgan; Heidi M Sowter; Charles C Wykoff; Eamonn R Maher; Adrian L Harris; Peter J Ratcliffe; Patrick H Maxwell
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

6.  PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.

Authors:  Joshua E Logan; Nikayeh Mostofizadeh; Amrita J Desai; Erika VON Euw; Dylan Conklin; Veerauo Konkankit; Habib Hamidi; Mark Eckardt; Lee Anderson; Hsiao-Wang Chen; Charles Ginther; Eileen Taschereau; Peter H Bui; James G Christensen; Arie S Belldegrun; Dennis J Slamon; Fairooz F Kabbinavar
Journal:  Anticancer Res       Date:  2013-08       Impact factor: 2.480

7.  Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.

Authors:  Fengju Chen; Yiqun Zhang; Yasin Şenbabaoğlu; Giovanni Ciriello; Lixing Yang; Ed Reznik; Brian Shuch; Goran Micevic; Guillermo De Velasco; Eve Shinbrot; Michael S Noble; Yiling Lu; Kyle R Covington; Liu Xi; Jennifer A Drummond; Donna Muzny; Hyojin Kang; Junehawk Lee; Pheroze Tamboli; Victor Reuter; Carl Simon Shelley; Benny A Kaipparettu; Donald P Bottaro; Andrew K Godwin; Richard A Gibbs; Gad Getz; Raju Kucherlapati; Peter J Park; Chris Sander; Elizabeth P Henske; Jane H Zhou; David J Kwiatkowski; Thai H Ho; Toni K Choueiri; James J Hsieh; Rehan Akbani; Gordon B Mills; A Ari Hakimi; David A Wheeler; Chad J Creighton
Journal:  Cell Rep       Date:  2016-03-03       Impact factor: 9.423

8.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

9.  Loss of BAP1 function leads to EZH2-dependent transformation.

Authors:  Lindsay M LaFave; Wendy Béguelin; Richard Koche; Matt Teater; Barbara Spitzer; Alan Chramiec; Efthymia Papalexi; Matthew D Keller; Todd Hricik; Katerina Konstantinoff; Jean-Baptiste Micol; Benjamin Durham; Sarah K Knutson; John E Campbell; Gil Blum; Xinxu Shi; Emma H Doud; Andrei V Krivtsov; Young Rock Chung; Inna Khodos; Elisa de Stanchina; Ouathek Ouerfelli; Prasad S Adusumilli; Paul M Thomas; Neil L Kelleher; Minkui Luo; Heike Keilhack; Omar Abdel-Wahab; Ari Melnick; Scott A Armstrong; Ross L Levine
Journal:  Nat Med       Date:  2015-10-05       Impact factor: 53.440

10.  Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.

Authors:  Federico Pio Fabrizio; Manuela Costantini; Massimiliano Copetti; Annamaria la Torre; Angelo Sparaneo; Andrea Fontana; Luana Poeta; Michele Gallucci; Steno Sentinelli; Paolo Graziano; Paola Parente; Vincenzo Pompeo; Laura De Salvo; Giuseppe Simone; Rocco Papalia; Francesco Picardo; Teresa Balsamo; Gerardo Paolo Flammia; Domenico Trombetta; Angela Pantalone; Klaas Kok; Ferronika Paranita; Lucia Anna Muscarella; Vito Michele Fazio
Journal:  Oncotarget       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.